NSCLC

September 27th 2021

Judging by common end points such as overall survival and progression-free survival, results of a network meta-analysis show that Keytruda in combination with platinum-based chemotherapy achieves the best results among the immune checkpoint inhibitor therapies used to treat advanced nonsmall cell lung cancer.

September 14th 2021

Treatments aimed at certain mutations have proliferated and moved upstream to earlier-stage lung cancers. But there are many questions about insurance coverage and which tests to use to identify the biomarkers that help guide treatment.

September 9th 2021

A genomic analysis of the lung cancer tumors of 232 never smokers grouped them into three categories with musical names: piano, mezzo-forte and forte.

September 1st 2021

Though the study did not meet its endpoint, the strategy behind it remains under investigation.